Annual Congress Munich 2006

Saturday, 02.09.2006
Sunday, 03.09.2006
Monday, 04.09.2006
Tuesday, 05.09.2006
Wednesday, 06.09.2006

Citations should be made in the following way: Authors. Title. Eur Respir J 2006; 28: Suppl. 50, abstract number.

Material from 2006:

4395 Abstracts
610 Slide presentations
175 Webcasts
95 Handouts
175 Multimedia files

Material from 2006: Show

Airway regulation, provocation and monitoring - III

Thematic Poster Session
Chairs: P. Chanez (Montpellier, France), P. Carratu (Bari, Italy)

Download all media

Effects of salbutamol on gas exchange abnormalities and sputum neutrophilia induced by adenosine 5‘-monophosphate (AMP) in mild asthma H. A. Manrique, F. P. Gómez, A. M. Peña, E. N. Polverino, P. A. Muñoz, J. A. Barberá, J. Roca, R. Rodríguez-Roisín (Barcelona, Spain)
Peak flow variation, exhaled nitric oxide and sputum eosinophils correlate with airway hyperresponsiveness to mannitol and methacholine in steroid-naïve asthmatics C. Porsbjerg, J. Brannan, S. Anderson, V. Backer (Copenhagen NV, Denmark; Camperdown, Australia)
Effects of roflumilast on exhaled NO, airway hyperresponsiveness, and inflammatory markers in patients with asthma F. Kanniess, J. Beier, K. M. Beeh, K. Hertzberg, I. Delin, M. Kumlin, R. Koenen, D. Bredenbroeker, S. E. Dahlén, H. Magnussen (Grosshansdorf, Wiesbaden, Konstanz, Germany; Stockholm, Sweden)
Prostaglandin D₂ (PGD₂) and tryptase release into blood after adenosine and methacholine challenges in asthmatic patients G. Bochenek, E. Nizankowska, K. Nagraba, A. Gielicz, A. Szczeklik (Kracow, Poland)
Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD G. Prosperini, L. Spicuzza, G. Piccillo, C. Oliveri, G. U. di Maria, R. Polosa (Catania, Italy)
Exhaled nitric oxide (eNO) and pH in the exhaled breath condensate in asthmatic children: biomarkers of different inflammatory pathways? P. Martins, I. Caires, S. Torres, C. Borrego, N. Neuparth (Lisboa, Viseu, Aveiro, Portugal)
Exhaled NO levels in patients with chronic cough in Japan J. Hara, M. Fujimura, M. Abo, S. Furusho, N. Ohkura, Y. Ichikawa, K. Nobata, S. Myou (Kanazawa, Japan)
Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD A. D. Tahanovich, A. S. Smirnou, O. A. Golovach, L. M. Labanava (Minsk, Belarus)
Effect of theophylline on endogenous hydrogen sulfide in patients with COPD Y. H. Chen, W. Z. Yao, Y. L. Ding, B. Geng, M. Lu, M. W. Zhao, C. S. Tang (Beijing, China)
Systemic and airways‘ inflammation in healthy subjects of different ages G. E. Carpagnano, A. Spanevello, V. Turchiarelli, P. Carratu, M. Cagnazzo, R. Urbano, M. P. Foschino Barbaro (Foggia, Bari, Italy)
Does ozone cause an inflammation on nasal mucosa? D. V. Dokic, P. H. Howarth, Z. S. Arsovski (Skopje, Fyrom; Southampton, United Kingdom)
Endurance exercise causes apoptosis of inflammatory cells and no clear inflammatory activation in the airways of endurance athletes A. Paternò, L. Chimenti, A. Bonanno, A. Mirabella, L. Riccobono, R. Santagata, M. Di Bella, G. Morici, V. Bellia, M. R. Bonsignore (Palermo, Italy)
Changes of urotensin II in induced sputum and plasma of patients with COPD and asthma Y. H. Chen, W. Z. Yao, M. Lu, Y. L. Ding, M. W. Zhao, C. S. Tang (Beijing, China)
Effects of TNF-alpha on the human nasal mucosa in vivo H. D. Widegren, M. Korsgren, M. Andersson, L. Greiff (Lund, Sweden)
Development of a biomarker for lung inflammation in COPD through analysis of labeled leukocyte transit through the lung circulation E. H. Baker, A. Irwin, A. L. Brennan, B. Trost, A. Britten, S. Heenan, B. Peterson (London, United Kingdom; Groton, United States Of America)
Involvement of the airway vasculature in the late asthmatic response (LAR) to allergen G. W. Clarke, S. D. Greenaway, M. W. G. Lethbridge, M. W. Morgan, A. Greenough, B. J. O‘Connor (London, United Kingdom)